{"count": 4, "results": [{"_id": "22748604", "pmid": 22748604, "title": "Discontinuation of statin therapy due to muscular side effects: a survey in real life.", "journal": "Nutr Metab Cardiovasc Dis", "authors": ["Rosenbaum D", "Dallongeville J", "Sabouret P", "Bruckert E"], "date": "2013-09-01T00:00:00Z", "doi": "10.1016/j.numecd.2012.04.012", "meta_date_publication": "2013 Sep", "meta_volume": "23", "meta_issue": "9", "meta_pages": "871-5", "score": 50046.586, "text_hl": "BACKGROUNDS AND AIMS: To assess the burden of statin related @<m>DISEASE_Signs_and_Symptoms</m> @DISEASE_MESH:D012816 @@@muscular symptom@@@ in real life. ", "citations": {"NLM": "Rosenbaum D, Dallongeville J, Sabouret P, Bruckert E. Discontinuation of statin therapy due to muscular side effects: a survey in real life. Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):871-5. PMID: 22748604", "BibTeX": "@article{22748604, title={Discontinuation of statin therapy due to muscular side effects: a survey in real life.}, author={Rosenbaum D and Dallongeville J and Sabouret P and Bruckert E}, journal={Nutr Metab Cardiovasc Dis}, volume={23}, number={9}, pages={871-5}}"}}, {"_id": "16808312", "pmid": 16808312, "title": "[The effect of hypolipemic therapy with diet and simvastatin on the course of angina pectoris and the results of exercise stress test in patients with coronary artery disease].", "journal": "Pol Arch Med Wewn", "authors": ["Pułkowski G", "Fabisiak J", "Budzyński J", "Suppan K", "Swiatkowski M"], "date": "2005-08-01T00:00:00Z", "meta_date_publication": "2005 Aug", "meta_volume": "114", "meta_issue": "2", "meta_pages": "746-54", "score": 50044.887, "text_hl": "In all blood sampling and treadmill stress test were made, and next in all hypolipemic diet and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 20 mg were recommended. ", "citations": {"NLM": "Pułkowski G, Fabisiak J, Budzyński J, Suppan K, Swiatkowski M. [The effect of hypolipemic therapy with diet and simvastatin on the course of angina pectoris and the results of exercise stress test in patients with coronary artery disease]. Pol Arch Med Wewn. 2005 Aug;114(2):746-54. PMID: 16808312", "BibTeX": "@article{16808312, title={[The effect of hypolipemic therapy with diet and simvastatin on the course of angina pectoris and the results of exercise stress test in patients with coronary artery disease].}, author={Pułkowski G and Fabisiak J and Budzyński J and Suppan K and Swiatkowski M}, journal={Pol Arch Med Wewn}, volume={114}, number={2}, pages={746-54}}"}}, {"_id": "24472404", "pmid": 24472404, "title": "Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS.", "journal": "Int J Clin Pharmacol Ther", "authors": ["Fujimoto M", "Hosomi K", "Takada M"], "date": "2014-04-01T00:00:00Z", "doi": "10.5414/CP202033", "meta_date_publication": "2014 Apr", "meta_volume": "52", "meta_issue": "4", "meta_pages": "259-66", "score": 50044.68, "text_hl": "Analysis of individual statins showed that @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, and @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@ had significant disproportionality for voiding @<m>DISEASE_Signs_and_Symptoms</m> @DISEASE_MESH:D012816 @@@symptoms@@@, while @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@, @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @CHEMICAL_pitavastatin @CHEMICAL_MESH:C108475 @@@pitavastatin@@@, and @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@ had significant disproportionality for storage @<m>DISEASE_Signs_and_Symptoms</m> @DISEASE_MESH:D012816 @@@symptoms@@@. ", "citations": {"NLM": "Fujimoto M, Hosomi K, Takada M. Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS. Int J Clin Pharmacol Ther. 2014 Apr;52(4):259-66. PMID: 24472404", "BibTeX": "@article{24472404, title={Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS.}, author={Fujimoto M and Hosomi K and Takada M}, journal={Int J Clin Pharmacol Ther}, volume={52}, number={4}, pages={259-66}}"}}, {"_id": "10359730", "pmid": 10359730, "title": "Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.", "journal": "Circulation", "authors": ["Baller D", "Notohamiprodjo G", "Gleichmann U", "Holzinger J", "Weise R", "Lehmann J"], "date": "1999-06-08T00:00:00Z", "doi": "10.1161/01.cir.99.22.2871", "meta_date_publication": "1999 Jun 8", "meta_volume": "99", "meta_issue": "22", "meta_pages": "2871-5", "score": 50038.324, "text_hl": "Concomitantly, a regression of @<m>DISEASE_Signs_and_Symptoms</m> @DISEASE_MESH:D012816 @@@anginal symptoms@@@ was observed in most @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R, Lehmann J. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation. 1999 Jun 8;99(22):2871-5. PMID: 10359730", "BibTeX": "@article{10359730, title={Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.}, author={Baller D and Notohamiprodjo G and Gleichmann U and Holzinger J and Weise R and Lehmann J}, journal={Circulation}, volume={99}, number={22}, pages={2871-5}}"}}]}